Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
The press have turned former President Donald Trump's deliberation over potential running mates into an "Apprentice"-like spectacle, and team Trump is more than happy to play along....